S931 Initial 8-week Therapy with Tofacitinib in Moderate-to-Severe Ulcerative Colitis in a Real World Prospective Multicenter Study (TOUR)

Authors :: William Harlan
Gauree G. Konijeti
Bruce Salzberg
Xian Zhang
Millie D. Long
David Hudesman
Emily English
Maisa Abdalla
Monika Fisher
Timothy E. Ritter
John S. Hanson
Anita Afzali
Benjamin L. Cohen
Steven Polyak
Robert P. McCabe
Hans H Herfarth
Source :: American Journal of Gastroenterology. 116:S441-S442
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: Moderate to severe
medicine.medical_specialty
Tofacitinib
Hepatology
Multicenter study
business.industry
Internal medicine
Gastroenterology
Medicine
business
medicine.disease
Ulcerative colitis

Tools